Jung Cassie, Chief Operating Officer of Aquestive Therapeutics ($AQST), sold nearly $976,000 worth of company shares in three open market transactions over the past year. Her most recent sale occurred on March 10, 2026. These sales rank her 4,994th among 11,678 insiders by total value sold, below the average of about $8.6 million per insider and 6.4 transactions. Cassie made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | S | Common Stock | 45791 | $4.17 | 276,980.0000 | 122,003,113 | 14.19% | 0.04% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | A | Common Stock | 80000 | $0.00 | 322,771.0000 | 122,003,113 | 32.95% | 0.07% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 42500 | $0.00 | 42,500.0000 | 122,003,113 | 9999.99% | 0.03% |
| Oct. 15, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 98,871,369 | 100.00% | 0.03% |
| Oct. 15, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Common Stock | 25000 | $3.10 | 310,346.0000 | 98,871,369 | 8.76% | 0.03% |
| Oct. 15, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | S | Common Stock | 67575 | $7.01 | 242,771.0000 | 98,871,369 | 21.77% | 0.07% |
| Sept. 4, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Common Stock | 25000 | $0.71 | 347,526.0000 | 98,871,369 | 7.75% | 0.03% |
| Sept. 4, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 98,871,369 | 100.00% | 0.03% |
| Sept. 4, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 98,871,369 | 100.00% | 0.03% |
| Sept. 4, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | M | Common Stock | 25000 | $3.15 | 322,526.0000 | 98,871,369 | 8.40% | 0.03% |
| Sept. 4, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | S | Common Stock | 62180 | $5.00 | 285,346.0000 | 98,871,369 | 17.89% | 0.06% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | A | Common Stock | 80000 | $0.00 | 315,066.0000 | 98,871,369 | 34.03% | 0.08% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | F | Common Stock | 7361 | $2.65 | 307,705.0000 | 98,871,369 | 2.34% | 0.01% |
| March 9, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | F | Common Stock | 7997 | $2.65 | 299,708.0000 | 98,871,369 | 2.60% | 0.01% |
| March 10, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | F | Common Stock | 2182 | $2.54 | 297,526.0000 | 98,871,369 | 0.73% | 0.00% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 98,871,369 | 9999.99% | 0.04% |
| Nov. 26, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | Chief Operating Officer | S | Common Stock | 44 | $4.87 | 235,066.0000 | 0 | 0.02% | 0.00% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | F | Common Stock | 14120 | $4.88 | 235,110.0000 | 0 | 5.67% | 0.00% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | F | Common Stock | 8300 | $4.88 | 240,930.0000 | 0 | 3.33% | 0.00% |
| March 10, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | F | Common Stock | 1132 | $4.88 | 239,798.0000 | 0 | 0.47% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | A | Common Stock | 101250 | $0.00 | 249,230.0000 | 0 | 68.42% | 0.00% |
| March 10, 2023 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | F | Common Stock | 1365 | $0.00 | 147,980.0000 | 0 | 0.91% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Jung Cassie | SVP, Operations | A | Non-Qualified Stock Option (right to buy) | 50625 | $0.00 | 50,625.0000 | 0 | 9999.99% | 0.00% |